125 related articles for article (PubMed ID: 20667296)
1. Memantine-related psychotic symptoms in a patient with bipolar disorder.
Canan F; Ataoglu A
J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
[No Abstract] [Full Text] [Related]
2. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
Papageorgiou SG; Kontaxis T; Antelli A; Kalfakis N
J Clin Psychopharmacol; 2007 Aug; 27(4):407-8. PubMed ID: 17632233
[No Abstract] [Full Text] [Related]
3. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
[No Abstract] [Full Text] [Related]
4. Memantine for patients with Alzheimer disease.
Finucane TE
JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
[No Abstract] [Full Text] [Related]
5. First drug for moderate-to-severe Alzheimer's.
FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
[No Abstract] [Full Text] [Related]
6. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
7. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer disease and its management: a review.
Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
[TBL] [Abstract][Full Text] [Related]
9. Memantine for dementia?
Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of action of Alzheimer medications].
Alhainen K
Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
[No Abstract] [Full Text] [Related]
11. Alzheimer's disease: will advances made in the past turn the tide?
Semla TP
Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
[No Abstract] [Full Text] [Related]
12. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
Sevilla C; Jiménez Caballero PE; Alfonso V; González-Adalid M
Dement Geriatr Cogn Disord; 2009; 28(3):196-205. PubMed ID: 19738386
[TBL] [Abstract][Full Text] [Related]
13. Dementia.
Warner J; Butler R; Arya P
Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
[No Abstract] [Full Text] [Related]
14. Discontinuing donepezil or starting memantine for Alzheimer's disease.
Suzuki T
N Engl J Med; 2012 Jun; 366(23):2227-8; author reply 2228. PubMed ID: 22670911
[No Abstract] [Full Text] [Related]
15. Discontinuing donepezil or starting memantine for Alzheimer's disease.
Schneider LS
N Engl J Med; 2012 Mar; 366(10):957-9. PubMed ID: 22397659
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
17. Memantine reduces mania-like symptoms in animal models.
Gao Y; Payne RS; Schurr A; Hougland T; Lord J; Herman L; Lei Z; Banerjee P; El-Mallakh RS
Psychiatry Res; 2011 Aug; 188(3):366-71. PubMed ID: 21269711
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
19. Discontinuing donepezil or starting memantine for Alzheimer's disease.
Finucane MM; Finucane TE
N Engl J Med; 2012 Jun; 366(23):2227-8; author reply 2228. PubMed ID: 22670912
[No Abstract] [Full Text] [Related]
20. Long-term effects of Alzheimer's disease treatment.
Wimo A
Lancet Neurol; 2015 Dec; 14(12):1145-6. PubMed ID: 26515659
[No Abstract] [Full Text] [Related]
[Next] [New Search]
